Literature DB >> 8161254

Immunohistochemical characterization of leucocyte subpopulations in endometriotic lesions.

D J Oosterlynck1, F J Cornillie, M Waer, P R Koninckx.   

Abstract

Leucocyte subpopulations localized in endometriotic lesions were analysed using the avidin-biotin immunoperoxidase technique on 15 biopsies obtained by CO2 laser excision. Qualitative assessment of the leucocyte subpopulations was performed with a panel of antihuman monoclonal antibodies for leucocytes (anti-Hle-1), T-lymphocytes (anti-leu-4), T helper/inducer (anti-leu-3a), T suppressor/cytotoxic (anti-leu-2a), B cells (anti-leu-12), HLA-DR (anti-HLA-DR), macrophages (anti-leu-M3) and natural killer cells (anti-leu-7, anti-leu-11; anti-leu-19). Leucocyte common antigen (anti-Hle-1)-positive cells were present in all lesions and were the most frequent stromal leucocytes. Of these, the T lymphocytes are the most frequent subpopulation together with the macrophages. The CD4/CD8 ratio was 0.78. No anti-leu-7 and/or anti-leu-11-positive cells were found although a substantial amount of anti-leu-19-positive cells were found in each lesion. There were very few B cells present in the ectopic endometrial lesions. In conclusion, an important amount of cytotoxic lymphocytes (anti-leu-2a -and anti-leu-19-positive cells) and macrophages (anti-leu-M3) were found in the endometriotic lesions. The possible importance of these intraendometriotic leucocytes for the pathophysiology of endometriosis will be discussed.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8161254     DOI: 10.1007/bf02766646

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  17 in total

1.  Decreased natural killer cell activity in women with endometriosis.

Authors:  E Tanaka; F Sendo; S Kawagoe; M Hiroi
Journal:  Gynecol Obstet Invest       Date:  1992       Impact factor: 2.031

2.  Immunocytochemical characterization of the unusual large granular lymphocytes in human endometrium throughout the menstrual cycle.

Authors:  A King; V Wellings; L Gardner; Y W Loke
Journal:  Hum Immunol       Date:  1989-03       Impact factor: 2.850

3.  Endometrial lymphoid tissue: an immunohistological study.

Authors:  H Morris; J Edwards; A Tiltman; M Emms
Journal:  J Clin Pathol       Date:  1985-06       Impact factor: 3.411

4.  Ultrastructural comparison of endometriotic implants and eutopic endometrium.

Authors:  K W Schweppe; R M Wynn; F K Beller
Journal:  Am J Obstet Gynecol       Date:  1984-04-01       Impact factor: 8.661

5.  Deficient cellular immunity in endometriosis.

Authors:  W P Dmowski; R W Steele; G F Baker
Journal:  Am J Obstet Gynecol       Date:  1981-10-15       Impact factor: 8.661

6.  Women with endometriosis show a defect in natural killer activity resulting in a decreased cytotoxicity to autologous endometrium.

Authors:  D J Oosterlynck; F J Cornillie; M Waer; M Vandeputte; P R Koninckx
Journal:  Fertil Steril       Date:  1991-07       Impact factor: 7.329

7.  The natural killer activity of peritoneal fluid lymphocytes is decreased in women with endometriosis.

Authors:  D J Oosterlynck; C Meuleman; M Waer; M Vandeputte; P R Koninckx
Journal:  Fertil Steril       Date:  1992-08       Impact factor: 7.329

8.  Deficient antiendometrium lymphocyte-mediated cytotoxicity in patients with endometriosis.

Authors:  P Viganò; P Vercellini; A M Di Blasio; A Colombo; G B Candiani; M Vignali
Journal:  Fertil Steril       Date:  1991-11       Impact factor: 7.329

9.  Natural killer cell activity in endometriosis: correlation between serum estradiol levels and cytotoxicity.

Authors:  G G Garzetti; A Ciavattini; M Provinciali; N Fabris; M Cignitti; C Romanini
Journal:  Obstet Gynecol       Date:  1993-05       Impact factor: 7.661

10.  The immunocytochemical distribution of leukocytic subpopulations in human endometrium.

Authors:  B R Kamat; P G Isaacson
Journal:  Am J Pathol       Date:  1987-04       Impact factor: 4.307

View more
  7 in total

Review 1.  The endometrial immune environment of women with endometriosis.

Authors:  Júlia Vallvé-Juanico; Sahar Houshdaran; Linda C Giudice
Journal:  Hum Reprod Update       Date:  2019-09-11       Impact factor: 15.610

2.  Reciprocal communication between endometrial stromal cells and macrophages.

Authors:  Kathleen M Eyster; Keith A Hansen; Emily Winterton; Olga Klinkova; Donis Drappeau; Connie J Mark-Kappeler
Journal:  Reprod Sci       Date:  2010-07-02       Impact factor: 3.060

3.  Interleukin-4 stimulates proliferation of endometriotic stromal cells.

Authors:  Zhuo OuYang; Yasushi Hirota; Yutaka Osuga; Kahori Hamasaki; Akiko Hasegawa; Toshiki Tajima; Tetsuya Hirata; Kaori Koga; Osamu Yoshino; Miyuki Harada; Yuri Takemura; Emi Nose; Tetsu Yano; Yuji Taketani
Journal:  Am J Pathol       Date:  2008-07-03       Impact factor: 4.307

4.  Effect of GuiXiong Xiaoyi Wan in Treatment of Endometriosis on Rats.

Authors:  Zhixing Jin; Li Wang; Zhiling Zhu
Journal:  Evid Based Complement Alternat Med       Date:  2015-01-27       Impact factor: 2.629

5.  Macrophage-derived insulin-like growth factor-1 is a key neurotrophic and nerve-sensitizing factor in pain associated with endometriosis.

Authors:  Rachel Forster; Alexandra Sarginson; Atanaska Velichkova; Chloe Hogg; Ashley Dorning; Andrew W Horne; Philippa T K Saunders; Erin Greaves
Journal:  FASEB J       Date:  2019-07-10       Impact factor: 5.191

6.  The association between endometriosis and chronic endometritis.

Authors:  Akie Takebayashi; Fuminori Kimura; Yohei Kishi; Mitsuaki Ishida; Akimasa Takahashi; Akiyoshi Yamanaka; Kentaro Takahashi; Hiroshi Suginami; Takashi Murakami
Journal:  PLoS One       Date:  2014-02-18       Impact factor: 3.240

7.  Adipose tissue-derived mesenchymal stem cells reduce endometriosis cellular proliferation through their anti-inflammatory effects.

Authors:  Fatma Y Meligy; Dalia A Elgamal; Lobna A Abdelzaher; Maha Y Khashbah; Mohamed A El-Mokhtar; Ayat A Sayed; Abeer M Refaiy; Essam R Othman
Journal:  Clin Exp Reprod Med       Date:  2021-12-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.